ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
CytoDyn Inc (QB)

CytoDyn Inc (QB) (CYDY)

0.11995
0.00365
( 3.14% )
Actualizado: 10:50:07

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Estadísticas y detalles clave

Último Precio
0.11995
Postura de Compra
0.1199
Postura de Venta
0.12
Volume Operado de la Acción
940,548
0.115 Rango del Día 0.12
0.111 Rango de 52 semanas 0.418
Capitalización de Mercado [m]
Precio Anterior
0.1163
Precio de Apertura
0.115
Última hora de negociación
10:50:07
Volumen financiero
US$ 111,994
Precio Promedio Ponderado
0.119074
Volumen promedio (3 m)
2,598,686
Acciones en circulación
1,219,842,000
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-2.93
Beneficio por acción (BPA)
-0.04
turnover
-
Beneficio neto
-49.84M

Acerca de CytoDyn Inc (QB)

CytoDyn is a clinical-stage biotechnology company focused on the development and commercialization of leronlimab, an investigational humanized IgG4 monoclonal antibody (mAb) that is designed to bind to C-C chemokine receptor type 5 (CCR5), a protein on the surface of certain immune system cells that... CytoDyn is a clinical-stage biotechnology company focused on the development and commercialization of leronlimab, an investigational humanized IgG4 monoclonal antibody (mAb) that is designed to bind to C-C chemokine receptor type 5 (CCR5), a protein on the surface of certain immune system cells that is believed to play a role in numerous disease processes. CytoDyn is studying leronlimab in multiple therapeutic areas, including infectious disease, cancer, and autoimmune conditions. Mostrar más

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sitio web
Sede
Wilmington, Delaware, USA
Fundado
-
CytoDyn Inc (QB) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker CYDY. The last closing price for CytoDyn (QB) was US$0.12. Over the last year, CytoDyn (QB) shares have traded in a share price range of US$ 0.111 to US$ 0.418.

CytoDyn (QB) currently has 1,219,842,000 shares in issue. The market capitalisation of CytoDyn (QB) is US$141.87 million. CytoDyn (QB) has a price to earnings ratio (PE ratio) of -2.93.

CYDY Últimas noticias

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-0.00805-6.28906250.1280.1290.11522043260.12017814CS
4-0.01105-8.435114503820.1310.140.11525968590.12604223CS
12-0.01615-11.86627479790.13610.2090.11525986860.14311646CS
26-0.07505-38.48717948720.1950.3150.11127220050.15059007CS
52-0.06405-34.80978260870.1840.4180.11126939670.17220185CS
156-1.20005-90.91287878791.321.350.11122186360.34795611CS
260-0.19015-61.31892937760.310110.010.11131028192.01396308CS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
ISUNQiSun Inc (CE)
US$ 0.0007
(69,900.00%)
5.71k
TTCFQTattooed Chef Inc (CE)
US$ 0.0004
(39,900.00%)
34.65k
BNKLBionik Laboratories Corporation (CE)
US$ 0.0001
(9,900.00%)
123
HENCHero Technologies Inc (CE)
US$ 0.0001
(9,900.00%)
200k
TWOHTwo Hands Corporation (PK)
US$ 0.0001
(9,900.00%)
500.7k
CNVIFConavi Medical Corporation (PK)
US$ 0.0007
(-99.88%)
1.66k
SCNGSC Holdings Corporation (CE)
US$ 0.000001
(-99.50%)
55k
FUNFFFansUnite Entertainment Inc (CE)
US$ 0.000001
(-99.50%)
1,000
FCGDFirst Colombia Gold Corporation (PK)
US$ 0.000001
(-99.00%)
2.26M
CBGLCannabis Global Inc (PK)
US$ 0.000001
(-99.00%)
850k
GRLFGreen Leaf Innovations Inc (PK)
US$ 0.00015
(50.00%)
209.5M
QEDNQED Connect Inc (PK)
US$ 0.0005
(25.00%)
78.09M
HCMCHealthier Choices Management Corporation (PK)
US$ 0.000001
(0.00%)
49.69M
EARIEntertainment Arts Research Inc (PK)
US$ 0.0001
(0.00%)
31.5M
CBTCXTRA Bitcoin Inc (PK)
US$ 0.0016
(-11.11%)
26.66M

CYDY Discussion

Ver más
Monroe1 Monroe1 10 minutos hace
Just wondering if those idiots are still down at the FDA who bad mouthed Nader and leronlimab? Bet some juicy stuff behind closed judges chamber door is going to oust those FDA miscreants. They may be gone already. At any rate, the cat's out of the bag and they will be gone... or will Bobby Jr. have to do it?

Time to buy IMO. More trials and other good news keeps happening since this turnaround began. The pps will catch up based on the merits of leronlimab with the team put together. In the scientific world sans the Covid lies, the mechanism of action of leronlimab is a buzz. Yep, the Bobby Jr. presence is already being felt as scientific editors and contributors are now being held accountable for nixing real science articles and promoting junk covid science. How gratifying to see liars and cheats get their due. I look for a huge surge in pps is the somewhat near future....even before Jan.20th. Know what you own. Leronlimab is a miracle discovery. In a health system devoid of scruples we suffered delay. Those days are ending fast. Pleasurable to know as CytoDyn advances while the working environment improves, leronlimab will have it's day.

Buying any dips worthy of my dollars.

$$$CYDY$$$ 2024 and onward. Great job Team.
"Fortunately, investment opportunities do not require actual blood to be spilled. Far less dramatic opportunities are pre¬sented every day. And the world’s greatest investors, in fact “The World’s Greatest Investor,” regularly employs market timing.
https://www.freemoneyfinance.com/2012/04/buy-when-theres-blood-in-the-street-and-why-buffett-is-a-market-timer.html
👍️0
djjazzyjeff djjazzyjeff 24 minutos hace
Lol I am?? I think you are confused! Lolll
👍️0
Since 2012 Since 2012 2 horas hace
Yet, here you are on a penny stock message board crying over a penny or two, impressive FF
👍️0
djjazzyjeff djjazzyjeff 14 horas hace
Because longs don't know how to read anything it's page 42 of the 10k moraaaaaaaannnsss
👍️0
djjazzyjeff djjazzyjeff 14 horas hace
Look how much they paid on interest alone in 2024! Ma gawd that's a lot of money for basically nothing! Lol you longs are so dumb 11 cents!!! Baaahahahhaahhahahahahh
👍️0
Blueheel1 Blueheel1 18 horas hace
Honestly, it's not just Tanya. There is not a single person at the company who has pulled off a turnaround like this. Tonya is a wealth manager, Jay built Quest - which seems like a successful company, but a totally different animal than turning around a biotech company. And the lawyer in his 30s (Tyler I think) has no experience and no clue.

This is all reflected in the market's vote on the company - a SP at near all time lows - lower than after the hold was lifted, lower than after the Amarex settlement, and much lower than since Jay took over as CEO. That tells you a lot about whether the market believes this team can pull this off before the cash runs out, which is sometime next Spring / Summer. It's not market manipulators, market makers, BP or anyone else. The simple reality is, if there was any real demand on the buy side, that would support the stock. But there is none.

I am still holding my shares - because at this point they are almost worthless. But mentally i have written this down to zero, which is why i haven't been on here in several weeks. It's just not worth the negative energy engaging in a company that is down almost 90% over the long term, with no real catalysts on the horizon. How they intend to raise capital will be interesting.
👍️0
kgromax kgromax 1 día hace
Thanks to all the pumpers of this fraud !

A nice "pump & dump" fraud operation, it had all the signs and has followed exactly the playbook.

Only very gullible investors remain (or distracted mom & pop). And the last pumpers
👍️0
big bopper1 big bopper1 2 días hace
Tanya has led us down down. For some reason she still is at the top. Why?
👍️0
The Dark KnaDDir The Dark KnaDDir 2 días hace
However, Scott Kelly, Nader Pourhassan, Tony Migliarese and others in management made off VERY well with their gifted cydy shares!
👍️0
kgromax kgromax 2 días hace
$10 to 12 cents

All these nice « dips » LOL

Cytodyn investors have lost 99% of their savings.

They were destroyed

LOL
👍️ 1 😴 1
big bopper1 big bopper1 2 días hace
I dont see stock moving from this news. The only way stock will move up is to have cancee trials .
👍️0
Monroe1 Monroe1 3 días hace
Mentioned here too just recently at the HIV conference in Peru.
https://www.hiv.gov/blog/hivr4p-2024-research-highlights-reproductive-health-while-on-prep-and-signals-to-guide-hiv-vaccines-and-cure

Leronlimab had superior outcomes.

$CYDY$ 2024-25
👍️ 3
docj docj 3 días hace
https://einsteinmed.edu/departments/medicine/divisions/pulmonary-medicine/patient-care/pulmonary-failure-lung-transplant/

Mention of leronlimab
👍️ 1
janice shell janice shell 6 días hace
I posted a link to an article about that in the post t which you're replying. Evidently you didn't bother to read it.
👍️0
Monroe1 Monroe1 6 días hace
Doesn't matter what you think. Remember you don't need to know anything about pharma. Well, you don't.

https://dailynewscycle.com/rfk-jr-unveils-plan-to-curb-big-pharmas-influence-on-u-s-healthcare/

You might want to read this and reconsider your post.

“You guys are collaborating with the pharmaceutical industry to lie to the American public about the efficacy and safety of these products,” Kennedy said. “We are going to sue you both civilly for damages and criminally for fraud.”

Get ready to rumble. $CYDY$ 2024-25
👍️ 1
janice shell janice shell 6 días hace
Bobby Jr. is going to trim and spin till BP and corrupt FDA personnel are tossed off the merry-go-round and sent flying and flopping like dizzy sick birds on a hot rock.

I really don't think he'll have much luck with that. He seems to be focused on anti-vaxxer propaganda. And things like raw milk that only serious cheese fanatics care about. But it also seems he doesn't care for the stranglehold the healthcare industry has on congress.

This was from early this morning:

RFK Jr vow to purge FDA sets up collision with Big Pharma

https://www.reuters.com/business/healthcare-pharmaceuticals/rfk-jr-vow-purge-fda-sets-up-collision-with-big-pharma-2024-11-15/

But the pharmas always fight back, and they have tons of money to spend on that.
👍️0
The Dark KnaDDir The Dark KnaDDir 7 días hace
More of a chance Jay gets deported to Iran than Merck even sniffing this steaming pile of dung, which by the way, since you are speaking of patents, lost its foundational patents.
👍️0
Monroe1 Monroe1 7 días hace
Bobby Jr. is going to trim and spin till BP and corrupt FDA personnel are tossed off the merry-go-round and sent flying and flopping like dizzy sick birds on a hot rock. Repercussions are going to cause some quantum shifts that propel overlooked highly potential drug candidates into the limelight. Take for example Merck's keytruda for cancer. They are on a buying spree...and they got the bucks...to shore up their keyturda which only works in perhaps 40% of the cases. Their patent will expire in a few years and much better drugs are in trials already outperforming it. So will they ...and others...be eyeballing leronlimab along with other promising candidates? You bet they will.
CytoDyn will break out once the public catches on and that will come after a block buster PR. I wonder what company Dr. Jay is liking most for collaboration as mentioned a few times. Yes docj, something is brewing with the Tanya connection stepping in. Things could get really interesting really quick .

Buying.
ps. God rest his soul, Fernando Venezuela was a great ball player. A shame he didn't have access to leronlimab under Compassionate Use. Maybe Bobbie can so something about such cases. We saved Eraps life and others so why not? I know the company, many companies for that matter, have to tippy toe around the FDA. Maybe those days will be over in the near future. Praying.

$CYDY$ 2024-25
https://petermcculloughmd.substack.com/p/breaking-news-robert-f-kennedy-jr
👍️ 2
docj docj 1 semana hace
Something Leronlimab may have an indication for in the future:

Fernando Valenzuela’s cause of death has been determined after the Dodgers legend died last month at the age of 63.

According to his death certificate, the broadcaster and former pitched died due to decompensated alcoholic cirrhosis and nonalcoholic steatohepatitis cirrhosis.
👍 2
docj docj 1 semana hace
It looks like Tanya Urbach’s current employer, Eagle Bay Advisors may have purchased 162,000 shares of Cytodyn per a 13F-HR form being filed.
👍️ 1
djjazzyjeff djjazzyjeff 2 semanas hace
Stock market: all time high. Bitcoin: all time high. This junk: all time low. Lolllllllllll moranssss!!!!
👍️0
The Dark KnaDDir The Dark KnaDDir 2 semanas hace
What would the number be if Scott Kelly is forced to tell under oath how many partners were "lined up" whenever he'd be on those video calls hinting about partners? Who knows, maybe one day he will be forced to tell once the class actions lawsuits arrive after Nadir is convicted.
👍️0
theswordman theswordman 2 semanas hace
These are the same folks that said CYDY had multi partners lined up just waiting for the hold to be lifted. As stated several times--ANYONE with reality KNOWS #1-- there were no partners "lined up" before the hold (s) #2--there was ZERO data/trial run during the hold. So what would line up any partner during a hold?? Just nonsense. This is just part of the phony narrative constantly being pumped @ livimmune
The latest (that will soon be shown to be nonsense) is how the second draining of the swamp will produce all these miracles across multiple "concerns"

There will soon be a narrative about record U S oil production (never mind that is NOW not in a few months )
There will soon be a narrative about some new beautiful wall that Mexico is paying for (again)
There will soon be narrative about replace obamacare (again)
Drug approvals without trials
All while promoting putin/xi/rocketman etc

All nonsense--but swallowed WHOLE by the livimmune crowd. Keep in mind THEY were also saying what a great job nodder was doing and that crowd along with ihang mods were and are still making excuses for their cult leaders. Q--ump--nodder--etc
👍️ 1 😴 1
big bopper1 big bopper1 2 semanas hace
Not sure why you think total replacement of fda will help cydy. Only clinical tests in cancer will do that
👍️ 1
Monroe1 Monroe1 2 semanas hace
Told you all this was coming for over a year now. Get ready, FDA is going under the knife for a facelift. Long long long overdue.
RFK Jr. Wants To Remove Entire Departments In FDA, Tells Corrupt Employees To “Pack Your Bags”
“I can get the corruption out of the agencies,” he said.

“That’s what I’ve been doing for 40 years. I’ve sued all those agencies. I have a Ph.D. in corporate corruption,” he added.
https://wltreport.com/2024/11/08/rfk-jr-wants-remove-entire-departments-fda-tells/?_bhlid=fdbd1bb4ccda9d97118fb0f3a2276fb80912327a
Coming together finally. We will have an FDA that will follow their mandate and policies as written. The revolving door between BP and the FDA
will go from a locked goose step to a chicken scratch. Pigeons will fly the coup. Dr. J already made great inroads and now with our latest additions to
the team that have a mountain of experience in dealing with new products and the FDA. Leronlimab already showing up as posted by docj. We are on the cusp of a new awakening for leronlimab as CCR5 is coming on strong.



"Companies in the CCR5 market are focusing on developing new drugs, such as CCR5 antagonists, to maintain a competitive edge. CCR5 antagonists are medications that block the CCR5 receptor on immune cells, preventing certain pathogens such as HIV from binding and entering these cells, thereby inhibiting infection and influencing immune responses. For instance, in February 2024, CytoDyn Inc., a US-based biotechnology firm, announced that the U.S. Food and Drug Administration (FDA) had lifted the clinical hold on leronlimab, a CCR5 antagonist also known as PRO 140. This approva[color=red]l allows CytoDyn to proceed with its planned clinical trial to evaluate leronlimab's effects on chronic inflammation. Leronlimab shows potential for treating various health conditions, including HIV and cancer, due to its ability to target multiple diseases.[/color" Per docj's posting from Globe Wire


Yes, a brave new world is rushing in. Get ready for it. Aldous surely must have been buddies with Edgar Cayce and Jean Dixon.
$CYDY$ 2024-25
👍️ 3 😂 1
docj docj 2 semanas hace
Mentions CYDY (CC chemokine receptor type 5 market)
https://www.globenewswire.com/news-release/2024/11/07/2976822/0/en/CC-Chemokine-Receptor-Type-5-Market-Research-Report-2024.html
👍️ 1
theswordman theswordman 2 semanas hace
Instead of monkey viral outbreak studies--the monkeys have decided to breakout

Dr Sacha keep those cages locked

https://apnews.com/article/monkeys-escape-alpha-genesis-south-carolina-66a78279a7abe57c5f8fd0953359368a
👍️ 1
docj docj 2 semanas hace
Fibrosis split from MASH at some point on the pipeline chart:

https://www.cytodyn.com/pipeline
👍️ 1
docj docj 2 semanas hace
https://www.targetedonc.com/view/fda-clears-phase-2-trial-of-leronlimab-for-microsatellite-stable-crc
👍️ 1
frtzblk frtzblk 2 semanas hace
you are correct, but I answered your statement already in my last message my way.
👍️0
djjazzyjeff djjazzyjeff 2 semanas hace
You been took by a snake oil salesman and you still can't admit it to yourself
👍️ 1
frtzblk frtzblk 2 semanas hace
Promise, promises were going on for too long a time. Promises of all kinds never impressed the stock market.

When we are told to wait 1 week, 6 weeks or even until mid year 2025 for anything potential, even a little bit that stock market will be aware of, that Leronlimab exists, what should we do to calm our angcyety ?

What can we do about, to calm our nerves, to go on and on ?
👍️0
Monroe1 Monroe1 2 semanas hace
DJIA up 1300 (3.07%) and rising. What gives? Perhaps the new health czar is going to make some bad ass changes to our health system. Sure would like to see those loudmouth FDA cronies who negated CytoDyn get the boot. Nader screwed up but so did the FDA and that is but one of his hole cards. Don't worry, it will all be whitewashed and CytoDyn's leronlimab is on track to be recognized for it's overall health benefits and safey for many indications. One day this will be a Nader three finger stock and it may well be my grandkids reap the big windfall. However, I do expect to be buying a greater quality bourbon among other goodies. Watch.
Thanks for the cheapies fellas. Taking full advantage of your actions.

RFK Jr. is just what the doctor ordered as Wall Street is now confirming!!!
Our jab competition Fuzzy Fizzle Fizer pfe is getting slammed again today, down hard. They know Burla is going to trial around the world.

Now more than ever. $$$CYDY$$$ 2024-2025
Dr. Jay and Tanya and Team, thanks for the turn around.
👍️ 2
fung_derf fung_derf 2 semanas hace
LOL.....It would be much smarter of you to gamble in Vegas than bet on this stock. And you can get a free drink!
Take that CYDY money, walk to the first Craps table you see, once the point is set, put the next bet on Don't Come.....take your winnings from there, and once point is made, move it all to Come....take your winnings and forget you even thought about throwing it away here.
😴 1
theswordman theswordman 2 semanas hace
Well he is charged with the lowest of the low hanging fruit. Prob a wrist slap from some plea deal. Just sad
👍️0
frtzblk frtzblk 2 semanas hace
The $ 2000.-__ refund I saved to invest in CYDY, I save for new year, when I go to Las Vegas and stay there for a week and when I come back I check on cydy, When I see ppromises for the year 2025, I wait till mid February to sell all my shares for a very low priice.
👍️0
The Dark KnaDDir The Dark KnaDDir 2 semanas hace
Oh Nader will be shouting out "they do fantastic job!" again, but this time about the DOJ after he's convicted and lead away in cuffs.
👍️0
djjazzyjeff djjazzyjeff 2 semanas hace
Are the Bollinger bands pinching durrrrr
👍️0
fung_derf fung_derf 2 semanas hace
Wall Street seems absolutely giddy over the news.
👍️0
frtzblk frtzblk 2 semanas hace
Every one is getting paid. Life is beautiful, as long as Leronlimab stays out of public circulation.

Just my opinion
👍️0
theswordman theswordman 2 semanas hace
CytoDyn is working with a team of experts to resume the exploration of Triple-Negative Breast Cancer

So NOT "dr" nodder and NOT dr kelly. No more micky mulholland and no more weed/wine. No more CRO kickbacks/fraud

No more airline partners and broken fax machines. No more using wrong SOC for BTD.

No more mistaking tropism for receptor occupancy. No more lack of dosing studies. No more BLA lies. No more stealing of shareholder equity. No more mother in law stories . No more $ 100 million + lawsuit manna stories. No more NDA made up crappola. No more skirting SEC regs. No more "they do fantastic job"
👍️0
big bopper1 big bopper1 2 semanas hace
Tanya doing great job. Please stock ar 12c. You guys that support her are delusional. Clinical trial that has no clinic .
👍️0
docj docj 2 semanas hace
Excerpt taken from the September Shareholder Letter:

In addition to CRC, CytoDyn is investigating the role for leronlimab in two other oncology indications via strategic and low-cost research and development opportunities, and in collaboration with several reputable institutions. I am pleased to announce that CytoDyn is working with a team of experts to resume the exploration of Triple-Negative Breast Cancer (“TNBC”), including colleagues from the University of Hawaii Cancer Center, MD Anderson Cancer Center, and the Pennsylvania Cancer and Regenerative Medicine Research Center. We will be working with this team in the coming months to design and conduct a preclinical TNBC study that will aim to confirm the mechanism of action of leronlimab in oncology and address the question of potential synergies with both antibody-drug conjugates and immune checkpoint inhibitors. The Company intends to use this preclinical study to form the basis for a potential partnership and better inform the design of a follow-up clinical study in patients with metastatic TNBC.
👍 3
docj docj 2 semanas hace
New SAB member:
Clinton Yam, MD, MS
Dr. Clinton Yam is an Associate Professor with dual appointments in the Departments of Breast Medical Oncology and Translational Molecular Pathology at The University of Texas MD Anderson Cancer Center. Dr. Yam is leader of the triple-negative breast cancer (TNBC) working group and Director of Team Science and Innovation in the Department of Breast Medical Oncology at MD Anderson. He is the principal investigator for several industry sponsored and investigator initiated clinical trials. Dr. Yam is very much involved in multidisciplinary efforts aimed at understanding the biology of TNBC to inform the design of innovative clinical trials to improve outcomes for patients with TNBC.
👍 2
docj docj 2 semanas hace
Who says they don't? We'll find out in due time. The trial does't start until early next year.
👍 2
big bopper1 big bopper1 2 semanas hace
Why announce zrial if they dont have a site and a partner
👍️0
theswordman theswordman 2 semanas hace
They are on their timeline--not anyone else. As we ----->>>> toward holidays--expect delays (trademark)

All shareholders are paying

They anncd their intended CRO

Site recruitment--then PIs at each etc take time. You might want Mayo/they might not feel mutual. When "it" ( RCT) is shown @ clin trials .gov many of those ??s will be answered.
👍️0
djjazzyjeff djjazzyjeff 2 semanas hace
Only people confused are longs watching this trash end red again lol
👍️ 1 😴 1
big bopper1 big bopper1 2 semanas hace
I will wait until mid december to let them give details. However,its unusual to announce a clinica trial that you will be enrolling patients and not say who you are teaming up with,where it is,who is paying for it. Hopefully ,everything will go smoothly.
👍️0
docj docj 2 semanas hace
Tanya has done a great job steering CYDY to calm waters. I do think she may have been too strict directing Tyler along the way PR wise but that is just my opinion. She isn't going anywhere until Dr NP's trial is over and any lawsuit she is named in is dealt with.
👍️0

Su Consulta Reciente

Delayed Upgrade Clock